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Abstract 
Solubility enhancement of poorly aqueous soluble drugs is an 
important aspect of formulation development. The objective of the 
study was to compare the aqueous solubility and dissolution 
characteristics of rifapentine enhanced by solid dispersion and 
inclusion complex technique. The inclusion complex with 
Hydroxypropyl-ß-cyclodextrin (HPß-CD) and ß-cyclodextrin (ß-CD) 
have been prepared by different methods in different ratios and 
found that the kneading method (AK1) shows the better 
enhancement of solubility in comparison to the solvent evaporation 
and physical mixing method. The drug content (99.5±0.13) and % 
inclusion yield (99.6%) was also highest with the kneading method 
(AK1). The characterization (FTIR and SEM) of the complexes 
shows that the drug shows amorphous form in the complexes. 
Amorphous form has higher dissolution efficiency than the 
crystalline drug. Infrared (IR) Spectroscopy and Scanning electron 
microscopy were performed to identify any physicochemical 
interaction between the drug and the carrier and its effect on 
dissolution behavior. 
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Introduction 
Aqueous solubility of any therapeutically active 
substance is a key property as it governs 
dissolution, absorption and thus the efficacy in 
vivo. Therapeutic effectiveness of a drug depends 
upon the bioavailability and ultimately upon the 
solubility of drug molecules. Solubility is one of 
the important parameter to achieve desired 
concentration of drug in systemic circulation for 
pharmacological response to be shown. Currently 
only 8% of new drug candidates have both high 
solubility and permeability. Solubilization of 
poorly aqueous soluble drug forms an important 
activity in formulation process. For many 
formulation scientists in the big pharma 
companies, it became clear in the early 1990s that 
they had to learn and invest much more into 
solubilizing/enhancing technologies like 
complexation of drug candidates with 
cyclodextrins, microemulsion (SMEDDS 
formulations), nanosuspension or solid dispersion 
formulation technologies having the potential to 
enhance bioavailability. The formation of 
inclusion complexes of a drug with nontoxic 
agent is a promising approach used to improve 
the dissolution properties of the drugs. 
Cyclodextrins (CDs) have been recognized as 
useful pharmaceutical excipients. Due to their 
exhaustive studies, intensive basic research and 
industrial production, they can be used widely in 
pharmaceutical industry. The most common 
natural CDs are a-cyclodextrin, ß-cyclodextrin 
and l-cyclodextrin, which are formed by six, 
seven, and eight glucose units respectively with 
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hydrophilic outer surface and hydrophobic cavity 
13 Inclusion complex improve. stability, 
solubility, dissolution rate and bioavailability. 
Furthermore, this study seeks to investigate 
kneading method, physical mixture, and solvent 
evaporation as a method for the preparation of 
these binary systems as well as their solid state 
characterization by employing analytical tools 
such as Fourier Transform infrared (FTIR) and 
Scanning electron microscopy (SEM). 
Rifapentine is an antibiotic in the rifampycin  
family of drugs that treats 
pulmonary tuberculosis (TB), it is poorly soluble 
in water. These drugs are derived from a fungus 
called Amycolatopsis mediterranei which 
originated from a pine forest outside of Nice, 
France. The drug's brand name is Prifkin, and it is 
marketed by Sanofi-Aventis. It was approved by 
the Food and Drug Administration in June 1998. 
Rifapentine has a potential advantage over 
rifampcin because its long half-life (13 
hours compared with 3 hours) could allow for 
less frequent dosing. 
 
Material And Methods 
Materials 
The Rifapentine was a gift from Lupin 
Pharmaceuticals, India and ß-CDs, HPß-CD was 
a gift from Merck Chemicals. All other chemicals 
and reagents used were of analytical grade.  
 
Methods 
The Preparation of drug-CD solid binary systems 
were prepared by different Techniques which are 
described below: (Table 1) 
 
Physical Mixture (PM):  
Physical mixture were prepared by simple 
blending in a glass mortar of accurately weighed 
quantites of drug(s) and carrier(s) for about one 
hour in ratio of 1:1 and passed through sieve 
no.85 and stored in dessicator over fused calcium 
chloride. 
 
Kneading Method (KN): 
A mixture of cyclodextrin (ß-CD & HPß-CD) 
and Rifapentine were weighed accurately in 
specified quantity. The mixture was wetted with 
water: methanol (50% v/v) and kneaded 
thoroughly for 45 min in glass mortar. Further, 
the products was dried at 40 0C for 48 hr, passed 
through sieve No.85 and stored in a desiccator 
over fused calcium chloride. 
 
Solvent-Evaporation method (SE): 
The Accurately weighed amount of Drug and 
cyclodextrin (HPß-CD & ß-CD) were dissolved 
in methanol to get a clear solution. The resulting 
solution was stirred at ambient temperature until 
complete evaporation of the solvent occurred. 
The resulting preparation were kept in desiccators 
for the least 48 hr and then grounded in a glass 
mortar for size reduction and passed through 
sieve no.85 and stored in desiccators over fused 
calcium chloride.   
 
 
Table 1:  Formulation code of Solid Dispersion and Inclusion Complex for different method of preparation. 
 Name of the Method         Drug: Polymer ratio             Inclusion complex(IC) 
                                                                                     HP-ß-CD          ß-CD 
Physical mixture                        1.1                          A                      B 
Kneading method                      1.1                           AK1                BK1 
                                                     1.2                         AK2                BK2 
                          1.3                        AK3                BK3   
Solvent Evaporation method         1.1                           AS1                 BS1 
                                                  1.2                          AS2                 BS2 
                           1.3                       AS3                BS3             
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Fig. 1: IR-Spectra of Rifapentine. 
 
Characterization of Inclusion Complex 
Fourier Transform Infra red spectroscopy 
(FTIR): 
FTIR spectra of prepared formulation were 
recorded on Shimadzu FTIR-8400 
spectrophotometer (Shimadzu Corporation, 
Kyoto, Japan). Potassium bromide pellet method 
was employed and background spectrum was 
collected under identical situation. Each spectrum 
was derived from single average scans collected 
in the region 400 – 4000 cm-1 at spectral 
resolution of 2 cm-2 and ratio against background 
interferogram. Spectra were analyzed by software 
supplied by Shimadzu.( Fig 3-5) 
 
Scanning electron microscopy: 
The surface morphology of the raw materials and 
of the optimized binary systems was examined by 
means of Phillips 1500, scanning electron 
microscope. The powders were previously fixed 
on a brass stub using double sided adhesive tape 
and then were made electrically conductive by 
coating in vacuums, with a thin layer of gold 
(approximately 300 Å), for 30s and at 30 W. The 
pictures were taken at an excitation voltage of 15 
Kv and a magnification of 750 or 5000X. SEM 
studies were carried out at Birbal Sahni Institute 
of Paleobotany, Lucknow. ( Fig 6) 
 
Drug content: 
Accurately weighed quantities of inclusion 
complex were suspended in 0.1N HCl, to extract 
the drug from inclusion complex. It was then 
shaken in mechanical shaker. After 24 hours, the 
filtrate was analyzed spectrophotometrically at 
480 nm for drug content against 0.1N HCl as 
blank. 
 
In vitro dissolution: 
The experiments were conducted according to the 
following procedure: 900 milliliters of 0.1N HCl, 
maintained at 37±0.5°C was used as a dissolution 
medium. The stirring speed of the paddle was at 
50 rpm. After the required amount of each 
sample had been placed into the dissolution 
medium, an aliquot portion of the solution was 
withdrawn at appropriate time intervals to be 
analyzed by spectrophotometer for the amount of 
the dissolved drug. Each point on the dissolution 
profiles represented the average of three 
determinations. (Table 2,3,4) 
 
Results and Discussion 
All inclusion complexs (ICs) were found to be 
fine and free flowing prepared by kneading 
method and solvent evaporation method as 
compare to physical mixture method with low 
standard deviation values in percent drug content 
ensured uniformity of drug content in each batch, 
all the dispersions contained 96±4% of the drug. 
IR spectra (figs.1-3) of pure rifapentine, HPß-CD 
and its ICs were not found to be identical, thus 
indicates interaction between rifapentine and 
carriers in the prepared ICs. This means that the 
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extent of complexation was less in the complexes 
made by physical mixing. While complexes made 
by kneading method showed better complexation, 
as their spectra were significantly different from 
the spectra of pure drug and HPß-CD.  
 
Table 2: Drug Content and Invitro release of prepared Inclusion complex of Rifapentine  & HP-ß-CD bykneading and 
solvent evaporation method.                                                                     
 
S.No.                    Kneading method     %vitro drug                    Solvent Evaporation method      
          
     Batch code          %Drug            %vitro drug               Batch code    % Drug       %vitro drug 
                                  Content±S.D         release                                             content±S.D          release 
                                                                                                                                                                                            
  1           AK1              99.5±0.13                99.23±0.25             AS1      98.68±0.13       97.22±0.77   
 
  2           AK2              98.98±0.20              96.11±1.14             AS2      97.78±0.62        94.50±1.15  
 
  3           AK3              98.08±0.12              93.99±1.01              AS3      96.92±0.21        91.50±1.33   
 
 
 
Fig 2: IR-Spectra of Formulation AK1. 
 
 
Table 3: Drug Content and Invitro release of prepared Inclusion complex of Rifapentine & ß-CD   by kneading and 
solvent evaporation method.                                                                         
 
S.No.                    Kneading method                                                  Solvent Evaporation method      
            
   Batch code          %Drug               %vitro drug       Batch code    % Drug       %vitro drug 
                               Content±S.D          release                                     content±S.D          release                              
 
  1           BK1              95.22±0.30              84.29±0.99       BS1         94.2±0.12       85.12±0.75   
 
  2           BK2              98.33±0.10              90.66±1.94       BS2         96.73±0.12        89.33±1.05   
 
  3           BK3              97.77±0.14              95.23±1.48       BS3         97.84±0.11        95.22±1.23   
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Fig 3: IR-Spectra of HP-BetaCyclodextrin 
 
Table 4: Drug Content and Invitro release of prepared Inclusion complex of Rifapentine by physical mixture 
HP-ß-CD                                        ß-CD 
           %Drug                 %vitro drug                            % Drug          %vitro drug 
          Content±S.D             release                                          content±S.D                    release 
98.1±0.25                69.32±1.55                 95.99±0.15                    64.32±1.4               
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Fig 4: Scanning electron micrograph of HP-ßCD (A), HP-ßCD:RIF physical mixture (B), RIF: HP-ß-CD kneading (C). 
 
 
Figure 5: Dissolution profiles of Rifapentine and mixtures of Rifapentine and ß-cyclodextrin in 0.1N HCl at  37±0.5°C 
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Figure 6: Dissolution profiles of Rifapentine and mixtures of Rifapentine and HPß-cyclodextrin in 0.1N HCl at 37±0.5°C 
  
  
Disappearance in the intensity of peak sharpness 
for kneaded and solvent evaporation initiate that 
complexation was practically complete.  Figure 4 
shows SEM images of the pure components and 
inclusion complex. HPß-CD existed in irregular 
shape mixture of smooth-surfaced particles with 
few smaller particles (10-30 µm). In the case of 
Inclusion Complex 1:1 by kneading method the 
particles presented a surface morphology more 
irregular and smaller to that of pure HPß-CD and 
physical mixture. These micrographs demonstrate 
the homogeneity of inclusion complex; it is 
impossible to distinguish the presence of 
rifapentine particle among the HPß-CD particles. 
The novel arrangements between rifapentine and 
HPß-CD might be responsible for the enhanced 
drug dissolution rate found for inclusion 
complex, in comparison to pure rifapentine. The 
improvement of dissolution may be due to 
reducing particle size of rifapentine and hence 
improving drug wettability and significantly 
improved dissolution. In the solid dispersion state 
because of kneading of rifapentine with the 
polymers, it was converted into amorphous form 
or change in crystal form may changes the 
different physicochemical properties. Figure 5 
shows the in vitro dissolution profiles of 
rifapentine from ICs containing various ratios of 
drug to HPß-CD in which max % drug release 
was obtained in batch AS3  (91.50±1.33). Figure 
6 shows the in vitro dissolution profiles of 
rifapentine from ICs containing various ratios of 
drug to ß-CD in which max % drug release was 
obtained in batch EK1 (95.5±0.21).In the case of  
the physical mixtures, the small rise in solubility 
when compared to, pure rifapentine is due to the 
rapid formation of inclusion complexes in the 
dissolution medium or to the wetting effect of 
HPß-CD. Incidentally, HPß-CD has surfactant-
like properties owing to the hydrophilicity of its 
exterior surface which can lower the interfacial 
tension between poorly soluble drugs and the 
dissolution medium, resulting in higher 
solubility. 
 
Conclusion 
The Inclusion complex with cyclodextrin have 
been prepared by different methods in different 
ratios and found that the kneading method (AK1) 
shows the better enhancement of solubility in 
comparison to the solvent evaporation and 
physical mixing method. The drug content and % 
inclusion yield was also highest with the kneaded 
method (AK1). 
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